Metabolic Basis of Polycystic Ovarian Syndrome; Indications for Biochemical Screening

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|16|1|61-71

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.16, Iss.1, 2016-03, pp. : 61-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome: Implications for Therapy

By Roldán B.  

American Journal of PharmacoGenomics, Vol. 4, Iss. 2, 2004-01 ,pp. : 93-107

Adis International

Access to resources Recommend Favorite

Therapy for polycystic ovarian syndrome

By Wei A.Y.   Pritts E.A.  

Current Opinion in Pharmacology, Vol. 3, Iss. 6, 2003-12 ,pp. : 678-682

Elsevier

Access to resources Recommend Favorite

Genetics of polycystic ovarian syndrome

By Fratantonio Enza   Vicari Enzo   Pafumi Carlo   Calogero Aldo E  

Reproductive BioMedicine Online, Vol. 10, Iss. 6, 2005-06 ,pp. : 713-720

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Emerging Metabolomics Biomarkers of Polycystic Ovarian Syndrome; Targeting the Master Metabolic Disrupters for Diagnosis and Treatment

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 3, 2018-04 ,pp. : 221-229

Bentham Science Publishers

Access to resources Recommend Favorite

Association Between Polycystic Ovary Syndrome and Metabolic Syndrome

By  

Current Medicinal Chemistry, Vol. 21, Iss. 35, 2014-11 ,pp. : 3999-4012

Bentham Science Publishers

Access to resources Recommend Favorite